Savara Inc.
Symbol: SVRA (NASDAQ)
3.78
▼ (-1.02%) -0.039
Company Description:
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Key Stats
- Today's Open: $3.84
- Today's High: $3.905
- Today's Low: $3.586
- Today's Volume: 1.08M
- Yesterday Close: $3.82
- Yesterday High: $3.865
- Yesterday Low: $3.695
- Yesterday Volume: 1.15M
- Last Min Volume: 0
- Last Min High: $3.797
- Last Min Low: $3.781
- Last Min VWAP: $0
Company Profile
- Name: Savara Inc.
- Website: https://www.savarapharma.com
- Listed Date: 1996-11-18
- Location: AUSTIN, TX
- Market Status: Active
- CIK Number: 0001160308
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $665.42M
- Round Lot: 100
- Outstanding Shares: 172.84M
- Asset Type: CS
RECENT FILINGS FOR SVRA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 10-Q | View |
| 2025-07-08 | SCHEDULE 13G | View |
| 2025-06-23 | 4 | View |
| 2025-06-06 | 8-K | View |
| 2025-06-02 | 4 | View |
| 2025-05-27 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-13 | 10-Q | View |
| 2025-04-25 | ARS | View |
| 2025-04-25 | DEFA14A | View |
| 2025-04-25 | DEF 14A | View |
| 2025-04-25 | 10-K/A | View |
| 2025-04-01 | 4 | View |
| 2025-03-31 | 8-K | View |
| 2025-03-27 | SCHEDULE 13D/A | View |
| 2025-03-27 | 10-K | View |
| 2025-03-26 | 8-K | View |
| 2025-03-21 | 3 | View |
Latest News on SVRA